CD4 and immunoglobulin G4-related sclerosing disease: As CD4+ CTLs were implicated in several immune-mediated fibroinflammatory diseases, such as IgG4-related disease and systematic sclerosis (12, 13, 23, 24), rapamycin is a promising potential intervention for GO, especially to prevent and/or avoid fibrotic complications (25).